The collaboration leverages Nyctea’s unique expertise and its proprietary Nyctea® platform technology to improve the purification process for a drug compound that AstraZeneca is developing within its Research and Development program. Under the collaboration, Nyctea Technologies will apply its proprietary Nyctea® platform for improving purification of advanced therapy medicinal products (ATMPs). The Nyctea® platform stands […]
Grenoble — Xenocs, a global leader in Small Angle X-ray Scattering (SAXS) technology, and Malvern Panalytical, renowned for its expertise in materials characterization, are pleased to announce a collaboration aimed at transforming pharmaceutical analytics. This joint marketing initiative will deliver a unique, comprehensive solution to the pharmaceutical sector’s analytical challenges. Through various initiatives, such as […]
New York, NY and Strasbourg, France – Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded internationally via a partnership with FAMECO Group ApS (“FAMECO” or the “Company”). Terms of the transaction were not disclosed. Founded in 2000 and headquartered in Strasbourg, France, FAMECO is an international […]
SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced that it has expanded its collaboration with AmplifyBio, a rapidly growing contract development and manufacturing organization, through the installation of a new AVATAR™ Foundry system as part of Xcellbio’s beta access program. The new instrument will […]
Irvine, CA — Zymo Research Corporation and BluMaiden Biosciences are joining forces to offer end-to-end clinical trial analytics and reporting services based on the human microbiome. This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan. The partnership combines Zymo Research’s expertise […]
License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services Dublin, Ireland, and Montreal, Canada: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Université de Montréal (‘UdeM’), a leading Canadian research institution renowned for scientific innovation and technology transfer, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants […]
Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applications REDWOOD CITY, Calif. — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and manufacturing license agreement with Alphazyme LLC, part of Maravai LifeSciences, for multiple […]
The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science, Technology, and Research (A*STAR), and Macrogen, today announced the opening of a […]
The nanopore sequencing pilot programme aims to expand our understanding of the causes of rare genetic disease and cancer and evaluate potential for future routine clinical use. Oxford Nanopore Technologies is entering into a strategic collaboration with UMC Utrecht, one of the leading academic medical centres in the Netherlands, that will aim to explore the […]
Illumina Is the genomic sequencing partner for Otsuka Pharmaceutical Japan’s blood cancer assay HemeSight®, the first-in-Japan comprehensive genomic profiling assay for blood cancer, recently received its first regulatory approval. ‘We are very pleased with the approval of HemeSight in Japan. As Otsuka Pharmaceutical’s technology partner for genomic sequencing, we are proud to support Otsuka and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
